Equity Incentive Plan (Tables)

9 Months Ended

Sep. 30, 2016

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

A summary of the status of the Company’s option plans as of September 30, 2016 and changes during the period then ended is presented below:

	Nine months ended September 30,
	Unaudited
	Number of options			Weighted average exercise price
Outstanding at beginning of year		10,134,829		$	8.20
Granted		2,363,575			13.61
Exercised		(828,787	)		0.24
Forfeited and cancelled		(133,364	)		17.19

Outstanding as of September 30, 2016		11,536,253			9.78

Exercisable options		5,887,411			5.05

Vested and expected to vest		11,329,415		$	9.71

Schedule of Fair Value of Equity Based Awards Using Black-Scholes Option Pricing Model

The fair value of equity-based awards was estimated using the Black-Scholes option-pricing model for all grants with the following underlying assumptions:

	Nine months ended September 30,					Year ended December 31,
	2016			2015		2015
	Unaudited					Audited
Stock Option Plans
Expected term (years)	6.25				6.25	6.25
Expected volatility	59.12%-61.65%			62.50% - 65.80%		59.00%-65.80%
Risk-free interest rate	1.23%-1.88%			1.75% - 1.90%		1.74%-2.05%
Dividend yield	0%			0%		0%
ESPP
Expected term (years)	0.42			-		-
Expected volatility		70.45	%	-		-
Risk-free interest rate		0.40	%	-		-
Dividend yield	0%			-		-

Schedule of Non-cash Share-based Compensation Expense Related to Company's Equity-Based Awards

The total non-cash share-based compensation expense related to all of the Company’s equity-based awards recognized for the three and nine months ended September 30, 2016 and 2015 and the year ended December 31, 2015 was:

	Three months ended September 30,				Nine months ended September 30,				Year ended December 31,
	2016		2015		2016		2015		2015
	Unaudited				Unaudited				Audited
Cost of revenues	$	160	$	35	$	471	$	54	$	174
Research, development and clinical trials		776		668		2,378		1,717		2,529
Sales and marketing		1,249		571		3,888		1,550		2,496
General and administrative		3,441		1,654		9,982		4,051		6,661
Total share-based compensation expense	$	5,626	$	2,928	$	16,719	$	7,372	$	11,860